Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
De Novo Minimal Change Disease After Kidney Transplantation Publisher



Alirezaei A1 ; Zare E2 ; Parvin M3 ; Nili F4 ; Bakhtiyari M5, 6
Authors

Source: Journal of Renal Injury Prevention Published:2018


Abstract

Post-transplant glomerular diseases (PTGN) have been documented frequently, although majority of them, are recurrences of primary diseases. In some cases, de novo glomerular diseases can develop in recipients. In this paper, a case of de novo minimal change disease (MCD) after non-related live donor kidney transplantation in a patient with a history of biopsy proven membranous nephropathy is described. A 25-year-old man with history of biopsy-proven idiopathic membranous glomerulopathy (MGN) who had been transplanted 3 weeks before referred to hospital, presented with peripheral edema and massive proteinuria. First kidney biopsy was compatible with acute cellular rejection with glomerulitis. The patient was treated with methylprednisolone. Panel reactive antibody (PRA) and C4d were negative. Anti- phospholipase A2 receptor (PLA2R) antibody was also negative. Another allograft biopsy was conducted and the result was highly suggestive of MCD. Thus final diagnosis was de novo MCD and proteinuria decreased successfully. © 2018 The Author(s).
Other Related Docs
13. Early Postkidney Transplantation Hypophosphatemia, Journal of Research in Medical Sciences (2020)
18. Bk Nephropathy in Renal Transplant Patients With Epididymo-Orchitis, Journal of Comprehensive Pediatrics (2018)